Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.

Disease markers - 1 Jan 2010

Ha Yun-Sok, Yan Chunri, Lym Min Su, Jeong Pildu, Kim Won Tae, Kim Yong-June, Yun Seok-Joong, Lee Sang-Cheol, Moon Sung-Kwon, Choi Yung Hyun, Kim Wun-Jae

Abstract excerpt

Although polymorphisms in glutathione S-transferase (GST) have been associated with the risk of bladder cancer (BC), few reports provide information about the development of BC. The aim of the present study was to investigate the effect of homozygous glutathione S-transferase-μ (GSTM1) and glutathione S-transferase-ϕ (GSTT1) deletions as prognostic markers in non-muscle-invasive bladder cancer (NMIBC). A total of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Neoplasm Recurrence, Local

Share to Regression Analysis

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21045267
DOI: 10.3233/DMA-2010-0729
PMCID: PMC3835386

Genes

GSTT1
GSTM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.PMID 21045267Read ↗

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.Semantic proximity Read ↗

Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.Semantic proximity Read ↗

GSTT1: a marker of the aggressiveness of bladder cancer.Semantic proximity Read ↗

The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.Semantic proximity Read ↗

Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients.Semantic proximity Read ↗

Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.Semantic proximity Read ↗

The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.Semantic proximity Read ↗

The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.Semantic proximity Read ↗

Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer.Semantic proximity Read ↗

Glutathione S-transferase P1 gene polymorphism and bladder cancer susceptibility: an updated analysis.Semantic proximity Read ↗

Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.